Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy.

Yann Neuzillet; Jean-françois Dreyfus; Jean-pierre Raynaud; Mathieu Rouanne; Marc Schneider; Morgan Roupret; Sarah Drouin; Marc Galiano; Xavier Cathelineau; Thierry Lebret; Henry Botto

Return

Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy.

Author: Yann NEUZILLET ¹ ; Jean-François DREYFUS ² ; Jean-Pierre RAYNAUD ³ ; Mathieu ROUANNE ¹ ; Marc SCHNEIDER ⁴ ; Morgan ROUPRET ⁵ ; Sarah DROUIN ⁵ ; Marc GALIANO ⁶ ; Xavier CATHELINEAU ⁶ ; Thierry LEBRET ¹ ; Henry BOTTO ¹
Author Information

1. Department of Urology, Hôpital Foch, UVSQ-Paris-Saclay University, Suresnes 92150, France.
2. Department of Clinical Research and Innovation, Hôpital Foch, UVSQ-Paris-Saclay University, Suresnes 92150, France.
3. Sorbonne University, Paris 75013, France.
4. Department of Urology, Hôpital Louis Pasteur, Colmar 68000, France.
5. Department of Urology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris 75013, France.
6. Department of Urology, Institut Mutualiste Montsouris, Paris-Descartes University, Paris 75014, France.
Publication Type:Journal Article
Keywords: erectile function; metabolic syndrome; quality of life; radical prostatectomy; testosterone
From: Asian Journal of Andrology 2021;23(5):520-526
CountryChina
Language:English
Abstract: This study aims to investigate whether clinical and biological preoperative characteristics of patients who were to undergo radical prostatectomy were associated with impairment in patient-reported quality of life (QoL) and erectile dysfunction immediately before intervention. We evaluated patient-reported outcomes among 1019 patients (out of 1343) of the AndroCan study, willing to score the Aging Male Symptom (AMS) and the International Index of Erectile Function 5-item (IIEF-5) auto-questionnaires. Univariate linear regression and robust multiple regression were used to ascertain the relationship between demographic, clinical, and hormonal parameters and global AMS or IIEF-5 scores. As a result, most patients (85.1') of the Androcan cohort agreed to complete questionnaires. Significantly higher IIEF-5 global scores were found in non-Caucasian and obese patients, with larger waist circumference, metabolic syndrome, diabetes mellitus, cardiovascular disease, hypertension, high blood sugar, concomitant medications, and hypogonadism, while the AMS global score was significantly higher in patients with larger waist circumference, metabolic syndrome, high blood pressure, raised glycemia, and concomitant medication. The IIEF-5 global score was correlated to age, dehydroepiandrosterone (DHEA), fat mass percentage, and androstenediol (D5). The AMS global score was significantly correlated to DHEA, D5, and DHEA sulfate. Finally, the multivariate models showed that QoL and erectile function were significantly affected, before surgery, by symptoms and signs that are usually considered as pertaining to the metabolic syndrome, while sexual hormones are essentially correlated to erectile dysfunction.